MARKET

NUVB-WS

NUVB-WS

Nuvation Bio Inc
NYSE
0.0041
-0.0113
-73.38%
Closed 15:59 02/09 EST
OPEN
0.0154
PREV CLOSE
0.0154
HIGH
0.0188
LOW
0.0040
VOLUME
139.29K
TURNOVER
0
52 WEEK HIGH
0.6525
52 WEEK LOW
0.0040
MARKET CAP
--
P/E (TTM)
-0.0064
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NUVB WS last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at NUVB WS last week (0126-0130)?
Weekly Report · 02/02 09:16
Weekly Report: what happened at NUVB WS last week (0119-0123)?
Weekly Report · 01/26 09:16
Weekly Report: what happened at NUVB WS last week (0112-0116)?
Weekly Report · 01/19 09:17
Weekly Report: what happened at NUVB WS last week (0105-0109)?
Weekly Report · 01/12 09:17
Weekly Report: what happened at NUVB WS last week (1229-0102)?
Weekly Report · 01/05 09:16
Weekly Report: what happened at NUVB WS last week (1222-1226)?
Weekly Report · 12/29/2025 09:16
Weekly Report: what happened at NUVB WS last week (1215-1219)?
Weekly Report · 12/22/2025 09:16
More
About NUVB-WS
Nuvation Bio Inc. is a global biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. Its programs include taletrectinib (ROS1 inhibitor), safusidenib (mIDH1 inhibitor), NUV-1511 (drug-drug conjugate), and NUV-868 (BET inhibitor). The Company's Taletrectinib is an oral, potent, central nervous system-active, selective, ROS1 inhibitor specifically designed for the treatment of patients with ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1(mIDH1). NUV-1511, a clinical-stage drug-drug conjugate (DDC), fuses a targeting agent to a widely used chemotherapy agent. Its NUV-868 is a BD2-selective, oral, small molecule bromodomain and extra-terminal (BET) inhibitor that inhibits BRD4.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB WS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB WS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB-WS stock methods without spending real money on the virtual paper trading platform.